Literature DB >> 18324657

Utility of liver allograft biopsy obtained at procurement.

Irene J Lo1, Jay H Lefkowitch, Nikki Feirt, Barbara Alkofer, Cindy Kin, Benjamin Samstein, James V Guarrera, John F Renz.   

Abstract

Extended-donor criteria (EDC) liver allografts potentiate the role of procurement biopsy in organ utilization. To expedite allocation, histologic evaluation is routinely performed upon frozen-section (FS) specimens by local pathologists. This descriptive study compares FS reports by local pathologists with permanent-section (PS) evaluation by dedicated hepatopathologists, identifies histologic characteristics underrepresented by FS evaluation, and evaluates the efficacy of a biopsy decision analysis based on organ visualization. Fifty-two liver transplants using EDC allografts evaluated by FS with PS were studied. Pathologic worksheets created by an organ procurement organization were applied in 34 FS. PS analysis included 7 staining procedures for 8 histologic criteria. PS from 56 additional allografts determined not to require donor biopsy were also analyzed. A high correlation was observed between FS and PS. Underestimation of steatosis by FS was associated with allograft dysfunction. Surgical assessment of cholestasis, congestion, and steatosis was accurate whereas inflammation, necrosis, and fibrosis were underestimated in allografts suffering parenchymal injury. In conclusion, the correlation between FS and PS is high, and significant discrepancies are rare. Biopsy is not a prerequisite for EDC utilization but is suggested in hepatitis C, hypernatremia, donation after cardiac death, or multiple EDC indications. Implementation of a universal FS worksheet could standardize histologic reporting and facilitate data collection, allocation, and research.

Entities:  

Mesh:

Year:  2008        PMID: 18324657     DOI: 10.1002/lt.21419

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  6 in total

Review 1.  Donor liver histology--a valuable tool in graft selection.

Authors:  Christa Flechtenmacher; Peter Schirmacher; Peter Schemmer
Journal:  Langenbecks Arch Surg       Date:  2015-03-26       Impact factor: 3.445

Review 2.  [Donor liver histology : Joint recommendations of the DGP, DTG and DSO].

Authors:  C Schleicher; H-H Kreipe; P Schemmer; C P Strassburg; C-L Fischer-Fröhlich; A Rahmel; C Flechtenmacher
Journal:  Chirurg       Date:  2019-11       Impact factor: 0.955

3.  Oil Red O-assessed macrosteatosis in liver transplant donor biopsies predicts ischemia-reperfusion injury and clinical outcome.

Authors:  Henning Reis; Patricia T Peterek; Jeremias Wohlschlaeger; Gernot M Kaiser; Zoltan Mathe; Benjamin Juntermanns; Georgios C Sotiropoulos; Ulrich Beckhove; Ali Canbay; Ulrike Wirges; Andre Scherag; Juergen-Walter Treckmann; Andreas Paul; Hideo Andreas Baba
Journal:  Virchows Arch       Date:  2013-12-03       Impact factor: 4.064

4.  Indocyanine green clearance test in liver transplantation: defining cut-off levels for graft viability assessment during organ retrieval and for the prediction of post-transplant graft function recovery - the Liver Indocyanine Green (LivInG) Trial Study Protocol.

Authors:  Alessandro Coppola; Giuseppe Bianco; Quirino Lai; Giuseppe Marrone; Miriam Caimano; Salvatore Agnes; Gabriele Spoletini
Journal:  BMJ Open       Date:  2022-08-01       Impact factor: 3.006

5.  AI finally provides augmented intelligence to liver surgeons.

Authors:  Nicolas Golse
Journal:  EBioMedicine       Date:  2020-10-20       Impact factor: 8.143

6.  Deep learning quantification of percent steatosis in donor liver biopsy frozen sections.

Authors:  Lulu Sun; Jon N Marsh; Matthew K Matlock; Ling Chen; Joseph P Gaut; Elizabeth M Brunt; S Joshua Swamidass; Ta-Chiang Liu
Journal:  EBioMedicine       Date:  2020-09-24       Impact factor: 8.143

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.